Episode 14

Racetams Explained: Do These "Smart Drugs" Really Work?

Racetams are a group of nootropics that are known to improve wakefulness and focus. In this video, we will explore the science behind these compounds and their potential benefits.

Racetams Explained

Unpacking Racetams: Are These “Smart Drugs” Right for You?

In the ever-evolving landscape of cognitive enhancement, a class of synthetic compounds known as racetams has garnered significant attention. Often referred to as “nootropics” or “smart drugs,” these substances are believed to boost brain function, affecting memory, focus, and overall cognitive performance. However, the science behind their efficacy is mixed, and their legal status varies widely across the globe, leading to a complex picture for potential users.

What Exactly Are Racetams?

Racetams are a distinct family of synthetic compounds characterized by a shared pyrrolidone nucleus. Chemically, they are cyclic derivatives of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, and structurally resemble pyroglutamic acid, an analogue of the excitatory neurotransmitter glutamic acid. Key members of this family include Piracetam, Aniracetam, Oxiracetam, Pramiracetam, and Phenylpiracetam, many of which are recognized for their nootropic properties. Beyond cognitive enhancement, some racetams, such as levetiracetam, brivaracetam, and seletracetam, function as anticonvulsants.

While the exact mechanism of action for racetams remains elusive after decades of research, current understanding suggests they modulate neurotransmission, particularly within the cholinergic and glutamatergic systems. Piracetam and Aniracetam, for example, act as positive allosteric modulators of the AMPA receptor, which can lead to an influx of calcium ions and an increase in AMPA receptor binding sites, hypothesized to contribute to their memory-enhancing effects. This means they don’t directly activate receptors in the traditional sense, but rather fine-tune existing brain signals.

A Closer Look at Specific Racetams

Let’s delve into three commonly discussed racetams:

  • Piracetam:

    • Considered the “parent compound” of the racetam class, Piracetam was first synthesized in the 1960s.
    • It is a prescription drug in many European countries and Japan, used for conditions like cognitive disorders, vertigo, cortical myoclonus, dyslexia, and sickle cell anemia.
    • In the United States, however, Piracetam is not approved by the FDA for any medical use and is considered an “unapproved drug,” meaning its use in dietary supplements, food, or medicine is unlawful.
    • Clinical evidence for Piracetam’s cognitive benefits is mixed and often based on dated studies. While some reviews suggest benefits in older individuals with cognitive impairment, studies on Alzheimer’s or Parkinson’s dementia patients generally show no significant improvement.
    • A meta-analysis indicated that Piracetam may be effective in improving short-term cognitive performance in patients who have undergone coronary bypass surgery.
    • It has also shown efficacy in reducing breath-holding attacks in young children and improving some reading skills in children with dyslexia.
    • Piracetam is generally well-tolerated and has low acute toxicity, with side effects typically limited to mild issues like stomach upset, high blood pressure, or weight gain at high doses.
  • Aniracetam:

    • First made by Hoffmann-La Roche in the 1970s, Aniracetam is sold as a prescription drug in some European countries like Greece and Italy. It is not approved by the FDA for medical or dietary supplement use in the US.
    • It has been used to treat dementia following stroke and in Alzheimer’s disease. Rodent studies showed psychoactive effects, improving learning and memory, and it has been identified as a nootropic with potential anxiolytic effects in mice.
    • Aniracetam can improve visual recognition, motor performance, and general intellectual function in humans, particularly memory in individuals with cognitive impairment. It may also improve mood in people with memory problems.
    • Crucially, in studies with normal, healthy mice, Aniracetam did not alter cognitive or affective behavior, suggesting its benefits are more pronounced in states of cognitive impairment rather than enhancing already optimal function.
    • Generally, it has few reported side effects and an “excellent tolerability profile”. However, high doses may lead to mood changes and severe insomnia.
  • Oxiracetam:

    • This nootropic is also classified as a mild stimulant. It is not approved by the FDA for any medical use in the United States.
    • Preclinical studies in rats with vascular dementia (VaD) suggest Oxiracetam can ameliorate learning and memory deficits and reduce neuronal damage. This is particularly significant as no drug has yet been globally approved for VaD treatment.
    • Some research indicates it might have a modest effect in preventing cognitive decline, especially when combined with physical exercise.
    • However, human studies on Oxiracetam’s effect in Alzheimer’s disease are conflicting: one double-blind, placebo-controlled study found it ineffective, while another source suggests potential benefits in reversing cognitive deficits in Alzheimer’s. This highlights the need for more consistent high-quality human trials.
    • Oxiracetam is generally considered safe even at high doses for prolonged periods.

Who Benefits Most?

A consistent theme across clinical investigations of Piracetam, Aniracetam, and Oxiracetam is that their benefits are more pronounced in individuals experiencing pre-existing cognitive impairments. This includes:

  • Patients recovering from coronary bypass surgery.
  • Older adults with documented cognitive decline or mild dementia.
  • Patients with encephalopathy from various causes like cranial trauma, inflammation, or strokes.
  • Individuals with specific conditions like cortical myoclonus, dyslexia, vertigo, and sickle cell anemia.

This suggests that racetams primarily function as restorative or supportive agents for underlying physiological or neurological impairments, rather than acting as “smart drugs” that significantly boost already optimal cognitive systems in healthy individuals.

Potential Side Effects and How to Mitigate Them

While racetams are generally considered to have low toxicity and good tolerability, they are not without potential side effects. The most frequently reported adverse effects across the racetam class include:

  • Headaches: This is a very common issue, often attributed to an increased demand on the brain’s cholinergic system.
    • Mitigation: Co-supplementation with a choline source like Alpha-GPC or Citicoline is frequently recommended. Choline is a precursor to acetylcholine, and its supplementation can help balance acetylcholine levels, thereby reducing headaches and potentially enhancing the racetam’s efficacy, especially in aged subjects.
  • Gastrointestinal discomfort: Symptoms like nausea, stomach cramps, and diarrhea can occur.
    • Mitigation: Taking racetams with food and starting with a lower dose may help.
  • Insomnia or over-stimulation: Due to their stimulating properties, especially with Oxiracetam, taking them too late in the day can disrupt sleep.
    • Mitigation: It’s generally recommended to take racetams earlier in the day.
  • Anxiety or irritability: Some individuals, particularly those sensitive to stimulants, may experience these feelings.
    • Mitigation: Reducing the dosage or discontinuing use may be advisable. Combining Aniracetam with calming supplements like L-Theanine is also suggested.
  • Dizziness or lightheadedness: These are additional potential side effects.
    • Mitigation: Ensuring proper hydration and taking the supplement with food might help.
  • Other reported side effects for Piracetam include hyperkinesia, nervousness, depression, asthenia, weight gain, increased libido, and hypersexuality.
  • Avoid abrupt withdrawal: This is particularly important for Piracetam, especially in epilepsy patients, as it may increase seizure frequency. This caution likely extends to other racetams as well.
  • Contraindications: Racetams should be avoided or used with caution in individuals with impaired liver or kidney function, bleeding disorders (especially cerebral hemorrhage), and during pregnancy or breastfeeding due to insufficient safety information. Older adults should use them with caution.

The legal status of racetams is not uniform across the globe, creating a challenging environment for consumers.

  • United States: Piracetam, Aniracetam, and Oxiracetam are not approved by the FDA for any medical use. They are classified as “new unapproved drugs,” which makes their marketing and sale as dietary supplements unlawful. Despite this, they are often purchased illegally online as “research chemicals”. The FDA has issued warning letters to companies illegally selling racetams as dietary supplements.
  • Europe: Piracetam is a prescription drug in many European countries. Aniracetam is available by prescription in Greece and Italy, and Oxiracetam is also a prescription-only substance in some European countries. In some countries like Hungary and the Czech Republic, Piracetam can be bought over-the-counter.
  • Australia: All racetams are Schedule 4 substances, meaning they are Prescription Only Medicines.
  • Japan: Piracetam is approved as a prescription drug. Aniracetam was previously prescribed for mental health conditions but has been removed from the Japanese market due to conflicting study results.
  • Canada: Piracetam is unscheduled, but its importation may be blocked by customs.

This varied regulatory landscape means that products bought online may vary significantly in purity and dosage, posing further risks to consumer safety.

Conclusion: Proceed with Caution

In summary, while racetams like Piracetam, Aniracetam, and Oxiracetam are touted as cognitive enhancers, the evidence consistently points to their efficacy being most notable in individuals with pre-existing cognitive impairments, rather than in healthy people seeking to boost already optimal function. They appear to act more as restorative or supportive agents.

Given their unapproved status in many regions (including the US) and the potential for side effects—which can often be mitigated by co-supplementation with choline—it is strongly advised to consult a licensed healthcare provider before initiating any racetam regimen. Relying on anecdotal claims from online forums without professional medical guidance can expose you to unnecessary risks and unverified product quality.

References

  1. 1

    https://pmc.ncbi.nlm.nih.gov/articles/PMC6741724/

  2. 2

    https://en.wikipedia.org/wiki/Racetam

  3. 3

    https://www.alzdiscovery.org/cognitive-vitality/ratings/piracetam

  4. 4

    https://en.wikipedia.org/wiki/Piracetam

  5. 5

    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0104443

  6. 6

    https://examine.com/supplements/piracetam/

  7. 7

    https://examine.com/supplements/piracetam/research/

  8. 8

    https://www.medicinenet.com/piracetam/article.htm

  9. 9

    https://www.mindlabpro.com/blogs/nootropics/legal-nootropics-guide

  10. 10

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peak-nootropics-llc-aka-advanced-nootropics-557887-02052019

  11. 11

    https://en.wikipedia.org/wiki/Aniracetam

  12. 12

    https://www.verywellhealth.com/the-benefits-of-aniracetam-89407

  13. 13

    https://www.tga.gov.au/resources/publication/scheduling-decisions-interim/publication-interim-decisions-amending-or-not-amending-current-poisons-standard-february-2019/12-racetams

  14. 14

    https://synapse.patsnap.com/article/what-are-the-side-effects-of-oxiracetam

  15. 15

    https://synapse.patsnap.com/article/what-are-the-side-effects-of-aniracetam

  16. 16

    https://pubmed.ncbi.nlm.nih.gov/7301036/

  17. 17

    https://synapse.patsnap.com/article/what-is-aniracetam-used-for

  18. 18

    https://en.wikipedia.org/wiki/Oxiracetam

  19. 19

    https://onlineprescribing.com/racetams-risks-legality-and-how-theyre-obtained-online/

  20. 20

    https://pubmed.ncbi.nlm.nih.gov/8061686/

  21. 21

    https://pmc.ncbi.nlm.nih.gov/articles/PMC6493642/

  22. 22

    https://pmc.ncbi.nlm.nih.gov/articles/PMC3881046/

  23. 23

    https://www.researchgate.net/publication/12465904_Cognitive_enhancement_effect_of_piracetam_in_patients_with_mild_cognitive_impairment_and_dementia

  24. 24

    https://www.webmd.com/vitamins/ai/ingredientmono-1597/piracetam

  25. 25

    https://www.scielo.br/j/bjmbr/a/Rzhb9H9DTFRBhNLXhnyKgGv/

  26. 26

    https://pubmed.ncbi.nlm.nih.gov/1444879/

  27. 27

    https://drugs.ncats.io/drug/P7U817352G

  28. 28

    https://www.healthline.com/health/aniracetam